Total Credits: 1 including 1 AOA Category 1-A Credit(s)
This brief program will address the sciences behind how OMT does influence healing and appears to be working in COVID treatment safely as well demonstrate several of the basic techniques being used by ONMM specialists and their residents in the field.
Learning Objectives
The NC Osteopathic Medical Association (NCOMA) is accredited by the American Osteopathic Medical Association to provide continuing medical education to physicians. NCOMA designates this program for a maximum of 1 AOA Category 1-A credit and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
Grievance Policy: The NCOMA strives to provide high quality CME activities by following the current guidelines issued by the American Osteopathic Association (AOA). All grievances should be in writing and should specify the nature of the grievance. Written grievances must be submitted to the Executive Director of NCOMA for review by e-mail. Visit the website at www.ncoma.org for contact info. Grievances that cannot be resolved will be sent to the AOA Council on CME.
charles smutny - CSmutny Treatment of CoViD-19 - OMT - Why When and With What
(2.85 MB)
|
Available after Purchase |
Dr. Charles J. Smutny III is currently an Assistant Professor of Osteopathic Neuromusculoskeletal Medicine at the Campbell University School of Osteopathic Medicine. He is board certified in Neuromusculoskeletal Medicine and is a Fellow of the American Academy of Osteopathy. He graduated from NYIT College of Osteopathic Medicine with honors 1994 completing the 5-year undergraduate fellowship in Osteopathic Manipulative Medicine. He carries a Certificate of Proficiency in Osteopathy in the Cranial Field and holds licensure in Acupuncture through the David Geffen School of Medicine at UCLA 2001. Dr. Smutny currently serves on the Board of Trustees of the NC Osteopathic Medical Association.
Speaker had no relevant financial relationships to disclose.
5 |
|
4 |
|
3 |
|
2 |
|
1 |
|